Alex de Winter is a director at GE Ventures, Healthcare.. Prior to GE, Alex was a partner at Mohr Davidow Ventures. At Mohr Davidow, Alex was a board director at On-Q-ity, as well as a board observer for CardioDx, Corventis, Crescendo Bioscience, didimi, DVS Sciences, and Personalis.. He started his career as a research scientist with 454. Life Sciences and Pacific Biosciences.. Alex has an MBA from UC Berkeley, a Ph.D. in chemistry from Stanford, and graduated magna cum laude from Amherst College.
